182 related articles for article (PubMed ID: 33931011)
1. Impact of donor age on liver transplant outcomes in patients with hepatocellular carcinoma: analysis of the SRTR database.
Zhou J; Huang Z; Chen Z; Xu F; Tong R; Zheng S
BMC Gastroenterol; 2021 Apr; 21(1):195. PubMed ID: 33931011
[TBL] [Abstract][Full Text] [Related]
2. Post-transplant infection improves outcome of hepatocellular carcinoma patients after orthotopic liver transplantation.
Chao JS; Zhao SL; Ou-Yang SW; Qian YB; Liu AQ; Tang HM; Zhong L; Peng ZH; Xu JM; Sun HC
World J Gastroenterol; 2019 Oct; 25(37):5630-5640. PubMed ID: 31602163
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma.
Lewin SM; Mehta N; Kelley RK; Roberts JP; Yao FY; Brandman D
Liver Transpl; 2017 Aug; 23(8):1015-1022. PubMed ID: 28340509
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
[TBL] [Abstract][Full Text] [Related]
5. A comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma.
Hernandez-Alejandro R; Croome KP; Drage M; Sela N; Parfitt J; Chandok N; Marotta P; Dale C; Wall W; Quan D
World J Gastroenterol; 2012 Aug; 18(31):4145-9. PubMed ID: 22919246
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular Carcinoma in the Setting of Chronic Hepatitis B Virus Infection: Tumor Recurrence and Survival Rates After Liver Transplantation.
Dugum M; Hanouneh I; Lopez R; Aucejo F; Eghtesad B; Zein N
Transplant Proc; 2015; 47(6):1939-44. PubMed ID: 26293077
[TBL] [Abstract][Full Text] [Related]
7. Donor characteristics and risk of hepatocellular carcinoma recurrence after liver transplantation.
Orci LA; Berney T; Majno PE; Lacotte S; Oldani G; Morel P; Mentha G; Toso C
Br J Surg; 2015 Sep; 102(10):1250-7. PubMed ID: 26098966
[TBL] [Abstract][Full Text] [Related]
8. The impact of viral hepatitis-related hepatocellular carcinoma to post-transplant outcomes.
Younossi ZM; Stepanova M; Saab S; Ahmed A; Lam B; Srishord M; Venkatesan C; Wai H; Henry L
J Viral Hepat; 2016 Jan; 23(1):53-61. PubMed ID: 26289820
[TBL] [Abstract][Full Text] [Related]
9. Impact of donor sex on hepatocellular carcinoma recurrence in liver transplantation after brain death.
Nakamura T; Sasaki K; Kojima L; Teo R; Inaba Y; Yamamoto T; Kimura S; Dageforde LA; Yeh H; Elias N; Bozorgzadeh A; Kawai T; Markmann JF
Clin Transplant; 2023 Aug; 37(8):e14989. PubMed ID: 37039506
[TBL] [Abstract][Full Text] [Related]
10. Donor factors similarly impact survival outcome after liver transplantation in hepatocellular carcinoma and non-hepatocellular carcinoma patients.
Salgia RJ; Goodrich NP; Marrero JA; Volk ML
Dig Dis Sci; 2014 Jan; 59(1):214-9. PubMed ID: 24077924
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Hepatitis B and C Among Liver Transplant Recipients With Hepatocellular Carcinoma: An Analysis of the Nationwide Inpatient Sample Database.
Lam PH; Obirieze AC; Ortega G; Nwokeabia I; Onyewu S; Purnell SD; Samimi MM; Weeks CB; Lee EL; Shokrani B; Frederick WA; Callender CO; Wilson LL
Transplant Proc; 2016; 48(1):123-7. PubMed ID: 26915856
[TBL] [Abstract][Full Text] [Related]
12. Differential impact of risk factors for tumor recurrence in hepatitis B and hepatitis C virus-infected patients undergoing liver transplantation for hepatocellular carcinoma.
Krasnodębski M; Grąt M; Masior Ł; Patkowski W; Krawczyk M
Ann Transplant; 2015 Feb; 20():70-5. PubMed ID: 25639825
[TBL] [Abstract][Full Text] [Related]
13. The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation.
Zhou J; Ye D; Zhang S; Ding J; Zhang T; Chen Z; Xu F; Ren S; Hu Z
BMC Gastroenterol; 2024 Feb; 24(1):85. PubMed ID: 38408903
[TBL] [Abstract][Full Text] [Related]
14. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
Moya A; Berenguer M; Aguilera V; Juan FS; Nicolás D; Pastor M; López-Andujar R; Rayón M; Orbis F; Mora J; De Juan M; Carrasco D; Vila JJ; Prieto M; Berenguer J; Mir J
Liver Transpl; 2002 Nov; 8(11):1020-7. PubMed ID: 12424715
[TBL] [Abstract][Full Text] [Related]
16. Liver transplantation for hepatocellular carcinoma within Milan Criteria in patients with Model for End-Stage Liver Disease score below 15: the impact of the etiology of cirrhosis on long-term survival.
Tandoi F; Ponte E; Saffioti MC; Patrono D; Mirabella S; Lupo F; Romagnoli R; Salizzoni M
Transplant Proc; 2013 Sep; 45(7):2711-4. PubMed ID: 24034029
[TBL] [Abstract][Full Text] [Related]
17. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.
Sandhu L; Sandroussi C; Guba M; Selzner M; Ghanekar A; Cattral MS; McGilvray ID; Levy G; Greig PD; Renner EL; Grant DR
Liver Transpl; 2012 Mar; 18(3):315-22. PubMed ID: 22140013
[TBL] [Abstract][Full Text] [Related]
18. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
[TBL] [Abstract][Full Text] [Related]
19. Pediatric liver transplantation for hepatocellular cancer and rare liver malignancies: US multicenter and single-center experience (1981-2015).
Vinayak R; Cruz RJ; Ranganathan S; Mohanka R; Mazariegos G; Soltys K; Bond G; Tadros S; Humar A; Marsh JW; Selby RR; Reyes J; Sun Q; Haberman K; Sindhi R
Liver Transpl; 2017 Dec; 23(12):1577-1588. PubMed ID: 28834194
[TBL] [Abstract][Full Text] [Related]
20. Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
Nafady-Hego H; Elgendy H; Nafady A; Uemoto S
Exp Clin Transplant; 2016 Apr; 14(2):207-14. PubMed ID: 26867537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
